August session APP Pharmacology Series presented by MGH and BWH APP Education Committees 2022-2023: Archived

Description

This activity provides on-demand archived lectures from the APP Pharmacology Series presented by MGH and BWH APP Education Committees 2022-2023. The educational series is designed to provide clinical content that is relevant to multiple disciplines throughout the Mass General Brigham organization. The lectures are designed to provide concise and accurate information that clinicians can use to provide evidence-based care. The lectures have been designed based on feedback from community members.


Course Directors:
Erin Schroeder, NP & Ariel Nowicki, PA-C

For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at partnerscpd@partners.org.

You may print individual certificates throughout the year; your cumulative list of completed activities is accessible on your transcript.

 

Target Audience

This activity is intended for all APPs, MDs, Pharmacists within Mass General Brigham.

 

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe the Public Health Problems of Pain and Inappropriate Opioid Use in America
  2. List 3 Examples of Best Practices Related to Opioid-Sparing, Multimodal Therapy
  3. Distinguish the Indications, Benefits and Risks of 3 Drug Classes Used For Pain  

Additional Information

Provided by: 

Provided by Mass General Brigham

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
  • 1.00 Pharmacist
Course opens: 
07/01/2022
Course expires: 
06/30/2023
Cost:
$0.00

Course Directors

Erin Schroeder, CNP
Nurse Practitioner, Gynecologic Oncology,
Massachusetts General Hospital

Ariel Nowicki, PA-C
Neurosurgery ICU Physician Assistant,
Brigham and Women's Hospital

Faculty

Paul Arnstein, RN, PhD, FAAN
Adjunct Professor Of Nursing,
MGH Institute of Health Professions


DISCLOSURE SUMMARY OF RELEVANT FINANCIAL RELATIONSHIPS

INELIGIBLE COMPANIES
Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:

  • Advertising, marketing, or communication firms whose clients are ineligible companies
  • Bio-medical startups that have begun a governmental regulatory approval process
  • Compounding pharmacies that manufacture proprietary compounds
  • Device manufacturers or distributors
  • Diagnostic labs that sell proprietary products
  • Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
  • Manufacturers of health-related wearable products
  • Pharmaceutical companies or distributors
  • Pharmacy benefit managers
  • Reagent manufacturers or sellers

For more information: https://accme.org/faq/what-accmes-definition-ineligible-company

MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence,
fair balance and ensure that the content is aligned with the interest of the public. 

The following planners reported no relevant financial relationship with an ineligible company:
Saksham Gupta, MD
Lindsay Harris, NP
Jessica L Logsdon, PA-C, MHA
Colleen McGauley, NP
Ariel Nowicki, PA-C
Joseph Parseghian, PA-C
Patricia Riley, NP
Darlene Sawicki, NP
Erin Schroeder, NP
Michael Schontz, PharmD, BCPS, BCCCP

The following speaker reported no relevant financial relationship with an ineligible company:

Paul Arnstein, RN, PhD, FAAN

ACCREDITATION

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditTM
Mass General Brigham designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy
This activity provides 1 contact hours (1 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-22-005-H04-P.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
  • 1.00 Pharmacist

Price

Cost:
$0.00
Please login or register to take this course.